Written by Douglas Feil, NBCF Chief Program Officer Disclaimer: The information provided in this article is for...
For decades, the standard path for women undergoing breast reconstruction following a mastectomy has been a binary...
In a sobering development for the biotechnology sector, Caribou Biosciences—a CRISPR-focused firm co-founded by Nobel laureate Jennifer...
In the rapidly evolving landscape of preclinical research, a paradigm shift is underway. For decades, the pathology...
In the rapidly shifting landscape of modern medicine, the intersection of patient advocacy, clinical expertise, and cutting-edge...
In a move that has sent tremors through the landscape of international diplomacy and global health security,...
Executive Summary: A Unified Vision for Patient Care A transformative shift in the Canadian healthcare landscape may...
OKLAHOMA CITY, OK – In a significant breakthrough that redefines our understanding of aggressive cancers, new research...
A significant setback for ArriVent BioPharma has sent its stock price into a tailspin, following the disappointing...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...
